[Federal Register Volume 69, Number 37 (Wednesday, February 25, 2004)]
[Notices]
[Page 8671]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-4080]



[[Page 8671]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Board of Scientific Advisors.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the contact person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Board of Scientific 
Advisors.
    Date: March 15-16, 2004.
    Time: March 15, 2004, 8:30 a.m. to 10:15 a.m.
    Agenda: Joint meeting of the NCI Board of Scientific Advisors 
and NCI Board of Scientific Counselors; report of the Director, NCI; 
legislative update, and ethics overview.
    Place: National Cancer Institute, Building 31, C Wing, 6 Floor, 
9000 Rockville Pike, Conference Room 10, Bethesda, MD 20892.
    Time: March 15, 2004, 10:15 a.m. to 6 p.m.
    Agenda: Ongoing and new business; reports of Program Review 
Group(s); and budget presentation; reports of Special Initiatives; 
RFA and RFP concept reviews; and scientific presentations.
    Place: National Cancer Institute, Building 31, C Wing, 6 Floor, 
9000 Rockville Pike, Conference Room 10, Bethesda, MD 20892.
    Time: March 16, 2004, 8:30 a.m. to 1 p.m.
    Agenda: Report of Special Initiatives; RFA and RFP concept 
reviews; and scientific presentations.
    Place: National Cancer Institute, Building 31, C Wing, 6 Floor, 
9000 Rockville Pike, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Paulette S. Gray, PhD, Acting Director, Deputy 
Director, Division of Extramural Activities, National Cancer 
Institute, National Institutes of Health, 6116 Executive Boulevard, 
8th Floor, Rm. 8001, Bethesda, MD 20892, 301-496-5147.
    This meeting is being published less than 15 days prior to the 
meeting due date to the scheduling conflicts.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda and any 
additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS.)

    Dated: February 18, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-4080 Filed 2-24-04; 8:45 am]
BILLING CODE 4140-01-M